PHARMACEUTICAL COMPOSITION AND ADMINISTRATIONS THEREOF

The present invention relates to pharmaceutical compositions containing a solid dispersion of N-[2,4-Bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide including formulations of the solid dispersions into powders, granules and mini-tablets, methods for manufacturing and...

Full description

Saved in:
Bibliographic Details
Main Authors CAESAR, JR. JOHN P, DAS LAURA, FAWAZ MAJED, DOKOU ELENI, GU CHONG-HUI, HURTER PATRICIA NELL, ISRANI MEGHNA JAI, KUZMISSION ANDREW G, KNEZIC DRAGUTIN, WANG HONGREN, JAMZAD SHAHLA, JOHNSTON MEGHAN M
Format Patent
LanguageEnglish
Published 11.09.2014
Subjects
Online AccessGet full text

Cover

Loading…
Abstract The present invention relates to pharmaceutical compositions containing a solid dispersion of N-[2,4-Bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide including formulations of the solid dispersions into powders, granules and mini-tablets, methods for manufacturing and processing the powders, granules and mini-tablets, and methods for treating cystic fibrosis employing the pharmaceutical composition.
AbstractList The present invention relates to pharmaceutical compositions containing a solid dispersion of N-[2,4-Bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide including formulations of the solid dispersions into powders, granules and mini-tablets, methods for manufacturing and processing the powders, granules and mini-tablets, and methods for treating cystic fibrosis employing the pharmaceutical composition.
Author DOKOU ELENI
DAS LAURA
ISRANI MEGHNA JAI
WANG HONGREN
GU CHONG-HUI
CAESAR, JR. JOHN P
KUZMISSION ANDREW G
HURTER PATRICIA NELL
JOHNSTON MEGHAN M
FAWAZ MAJED
KNEZIC DRAGUTIN
JAMZAD SHAHLA
Author_xml – fullname: CAESAR, JR. JOHN P
– fullname: DAS LAURA
– fullname: FAWAZ MAJED
– fullname: DOKOU ELENI
– fullname: GU CHONG-HUI
– fullname: HURTER PATRICIA NELL
– fullname: ISRANI MEGHNA JAI
– fullname: KUZMISSION ANDREW G
– fullname: KNEZIC DRAGUTIN
– fullname: WANG HONGREN
– fullname: JAMZAD SHAHLA
– fullname: JOHNSTON MEGHAN M
BookMark eNrjYmDJy89L5WQwC_BwDPJ1dHYNDfF0dvRRcPb3DfAP9gzx9PdTcPRzUXB08fX08wwOCXIECQUrhHi4Brn6u_EwsKYl5hSn8kJpbgZlN9cQZw_d1IL8-NTigsTk1LzUkvjQYCMDQxMjU1MTC2NHQ2PiVAEA68MrAw
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
ExternalDocumentID US2014255483A1
GroupedDBID EVB
ID FETCH-epo_espacenet_US2014255483A13
IEDL.DBID EVB
IngestDate Fri Aug 30 05:40:52 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language English
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_US2014255483A13
Notes Application Number: US201414286856
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20140911&DB=EPODOC&CC=US&NR=2014255483A1
ParticipantIDs epo_espacenet_US2014255483A1
PublicationCentury 2000
PublicationDate 20140911
PublicationDateYYYYMMDD 2014-09-11
PublicationDate_xml – month: 09
  year: 2014
  text: 20140911
  day: 11
PublicationDecade 2010
PublicationYear 2014
RelatedCompanies VERTEX PHARMACEUTICALS INCORPORATED
RelatedCompanies_xml – name: VERTEX PHARMACEUTICALS INCORPORATED
Score 2.9421268
Snippet The present invention relates to pharmaceutical compositions containing a solid dispersion of...
SourceID epo
SourceType Open Access Repository
SubjectTerms CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Title PHARMACEUTICAL COMPOSITION AND ADMINISTRATIONS THEREOF
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20140911&DB=EPODOC&locale=&CC=US&NR=2014255483A1
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1LS8NAEB5KFfWmVfFRJaDkFmyaR5NDkHSTkAh5kIf0VvLYgiBpsRH_vrNLqj31NrsDy-7CtzOzO_MtwLNpoJmstakkm2UtqaZSSmU9KyUNJUMt1dVkygqcw0j3C_VtoS0G8LmrheE8oT-cHBERVSPeO35eb_4vsRyeW7l9qT6wa_3q5ZYj9tExY29C7Dpzy01iJyYiIVaRiVHKdeg9q4ZiY6x0xBxpxrTvvs9ZXcpm36h453Cc4HhtdwED2o7glOz-XhvBSdg_eaPYo297CXri22loE7fIGYuBQOIwibOAXTIJduQIthMGUcB-Qea1wULuu6kbe1fw5Lk58SWcwPJvvcsi25-tcg3Ddt3SGxAwtmp0nRo1nTVqU69Ks6LoslC9ahpZppNbGB8a6e6w-h7OWJMlQ8jyGIbd1zd9QIvbVY98o34BziR_kA
link.rule.ids 230,309,786,891,25594,76906
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1LS8NAEB5KFetNq2K1akDJLdi0aZociqSbhESbB3lIbyWPLQiSFhvx7zu7pNpTb8sODLMLs_PYmW8AnnQNzWQxHkqynhWSoo8yKSsmmTTGlaZkymowZA3Onq86qfK6GC9a8LnrheE4oT8cHBE1qkB9r_l7vflPYpm8tnL7nH_g1vrFTqam2ETHDL0JddecTa0wMAMiEjJNY9GPOA29Z0UbGRgrHU0YPi9znt5nrC9ls29U7DM4DpFfVZ9Di1Zd6JDd7LUunHjNlzcuG-3bXoAaOkbkGcRKE4ZiIJDAC4PYZUkmwfBNwTA913fZFGTeGywkjhVZgX0Jj7aVEEdCAZZ_512m8b60oytoV-uKXoOAsVWpqlQr6KRUymKV6TlFl4WqeVnKMh30oH-I081h8gN0nMSbL-eu_3YLp4zECiNkuQ_t-uub3qH1rfN7fmm_7baCfQ
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=PHARMACEUTICAL+COMPOSITION+AND+ADMINISTRATIONS+THEREOF&rft.inventor=CAESAR%2C+JR.+JOHN+P&rft.inventor=DAS+LAURA&rft.inventor=FAWAZ+MAJED&rft.inventor=DOKOU+ELENI&rft.inventor=GU+CHONG-HUI&rft.inventor=HURTER+PATRICIA+NELL&rft.inventor=ISRANI+MEGHNA+JAI&rft.inventor=KUZMISSION+ANDREW+G&rft.inventor=KNEZIC+DRAGUTIN&rft.inventor=WANG+HONGREN&rft.inventor=JAMZAD+SHAHLA&rft.inventor=JOHNSTON+MEGHAN+M&rft.date=2014-09-11&rft.externalDBID=A1&rft.externalDocID=US2014255483A1